A Single-Dose, Open-Label, Randomized, Food Effect and Blinded, Randomized, Dose Proportionality Study in Healthy Volunteers With Bardoxolone Methyl.
Phase of Trial: Phase I
Latest Information Update: 01 Aug 2014
At a glance
- Drugs Bardoxolone methyl (Primary)
- Indications Cancer; Diabetic nephropathies; Haematological malignancies; Malignant melanoma; Non-alcoholic steatohepatitis; Pancreatic cancer; Solid tumours; Viral hepatitis
- Focus Pharmacokinetics
- Sponsors Reata Pharmaceuticals
- 30 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Oct 2011 New trial record